Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

ClinicalTrials.gov ID: NCT01207115

Public ClinicalTrials.gov record NCT01207115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 5:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Global Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Osteoarthritis Pain of the Knee

Study identification

NCT ID
NCT01207115
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
322 participants

Conditions and interventions

Interventions

  • ABT-652 Drug
  • Naproxen Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Apr 30, 2011
Completion
Apr 30, 2011
Last update posted
Jan 6, 2013

2010 – 2011

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Site Reference ID/Investigator# 37220 Chandler Arizona 85224
Site Reference ID/Investigator# 37223 Tempe Arizona 85282
Site Reference ID/Investigator# 37215 Tucson Arizona 85704
Site Reference ID/Investigator# 37221 Anaheim California 92801
Site Reference ID/Investigator# 37222 Burbank California 91505
Site Reference ID/Investigator# 35956 Chino California 91710
Site Reference ID/Investigator# 37053 La Mesa California 91942
Site Reference ID/Investigator# 37218 Lomita California 90717
Site Reference ID/Investigator# 37227 Milford Connecticut 06460
Site Reference ID/Investigator# 37229 Boynton Beach Florida 33472
Site Reference ID/Investigator# 37209 Ocala Florida 34471
Site Reference ID/Investigator# 37212 Plantation Florida 33317
Site Reference ID/Investigator# 35961 South Miami Florida 33143
Site Reference ID/Investigator# 37207 Valparaiso Indiana 46383
Site Reference ID/Investigator# 37217 Brooklyn Center Minnesota 55430
Site Reference ID/Investigator# 37228 St Louis Missouri 63141
Site Reference ID/Investigator# 35959 New York New York 10004
Site Reference ID/Investigator# 37211 Salisbury North Carolina 28144
Site Reference ID/Investigator# 37214 Duncansville Pennsylvania 16635
Site Reference ID/Investigator# 37205 Wyomissing Pennsylvania 19610
Site Reference ID/Investigator# 37208 Austin Texas 78705
Site Reference ID/Investigator# 37213 San Antonio Texas 78209-1744
Site Reference ID/Investigator# 35953 Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01207115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2013 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01207115 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →